Ensifentrine, a Novel PDE3 and PDE4 Inhibitor for the Treatment of COPD: Randomized, Double-Blind, Placebo-controlled, Multicenter, Phase III Trials (The ENHANCE Trials)

Cirulis MM, Auger WR, Benza RL, Channick RN, Chin K, Davis RD, Elliott CG, He F, Jain S, LaCroix AZ, Madani MM, McLaughlin V, Tapson[...]

Tincopa M, Bridi L, Vodkin I, Yilma M, Zhou K, Kwong A, Singh J, Mehta N, Kuo A, Hirose R, Wisel SA, Steggerda JA, Freise[...]

Conn BM, Durazo-Arvizu R, Wong CF, West AE, Chen D, Chan YM, Ehrensaft D, Garofalo R, Hidalgo MA, Rosenthal SM, Olson-Kennedy J. Gender Minority Stress[...]